MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jcrc.2020.11.023

Медицинская библиотека · Journal of critical care · 2020

Hepatic dysfunction impairs prognosis in critically ill patients with hematological malignancies: A post-hoc analysis of a prospective multicenter multinational dataset.

Bisbal Magali, Darmon Michael, Saillard Colombe, Mallet Vincent, Mouliade Charlotte, Lemiale Virginie, Benoit Dominique, Pene Frederic, Kouatchet Achille, Demoule Alexandre, Vincent Francois, Nyunga Martine, Bruneel Fabrice, Lebert Christine, Renault Anne, Meert Anne-Pascale, Hamidfar Rebecca, Jourdain Merce, Azoulay Elie, Mokart Djamel

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

PURPOSE: Hyperbilirubinemia is frequent in patients with hematological malignancies admitted to the intensive care unit (ICU). Literature about hepatic dysfunction (HD) in this context is scarce.

METHODS

We investigated the prognostic impact of HD analyzing a prospective multicenter cohort of 893 critically ill hematology patients. Two groups were defined: patients with HD (total bilirubin ≥33 μmol/L at ICU admission) and patients without HD.

RESULTS

Twenty one percent of patients were found to have HD at ICU admission. Cyclosporine, antimicrobials before ICU admission, abdominal symptoms, ascites, history of liver disease, neutropenia, increased serum creatinine and myeloma were independently associated with HD. Etiology remained undetermined in 73% of patients. Hospital mortality was 56.3% and 36.3% respectively in patients with and without HD (p < 0.0001). Prognostic factors independently associated with hospital mortality in HD group were, performance status >1 (OR = 2.07, 95% CI = 1.49-2.87, p < 0.0001), invasive mechanical ventilation (OR = 3.92, 95% CI = 2.69-5.71, p < 0.0001), renal replacement therapy (OR = 1.74, 95% CI = 1.22-2.47, p = 0.002), vasoactive drug (OR = 1.81, 95% CI = 1.21-2.71, p = 0.004) and SOFA score without bilirubin level at ICU admission (OR = 1.09, 95% CI = 1.04-1.14, p < 0.0001).

CONCLUSIONS

HD is common, underestimated, infrequently investigated, and is associated with impaired outcome in critically ill hematology patients. HD should be considered upon ICU admission and managed as other organ dysfunctions.

Для цитирования: Bisbal Magali, Darmon Michael, Saillard Colombe, Mallet Vincent, Mouliade Charlotte, Lemiale Virginie, Benoit Dominique, Pene Frederic, Kouatchet Achille, Demoule Alexandre, Vincent Francois, Nyunga Martine, Bruneel Fabrice, Lebert Christine, Renault Anne, Meert Anne-Pascale, Hamidfar Rebecca, Jourdain Merce, Azoulay Elie, Mokart Djamel. Hepatic dysfunction impairs prognosis in critically ill patients with hematological malignancies: A post-hoc analysis of a prospective multicenter multinational dataset.. Journal of critical care. 2020. DOI: 10.1016/j.jcrc.2020.11.023.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.